2019
DOI: 10.1016/j.carbpol.2019.04.075
|View full text |Cite
|
Sign up to set email alerts
|

Chitosan composite microparticles: A promising gastroadhesive system for taxifolin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
16
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 20 publications
(16 citation statements)
references
References 68 publications
0
16
0
Order By: Relevance
“…The use of Tax polymorphs, characterized by a better solubilization rate than Pristine-Tax, would consent to improve its efficacy and eventually extend its application field without the necessity of using excipients. In fact, reviewing the literature, several papers disclose the use of excipients as a strategy to increase Tax bioavailability [ 56 , 57 , 58 , 59 , 60 ].…”
Section: Resultsmentioning
confidence: 99%
“…The use of Tax polymorphs, characterized by a better solubilization rate than Pristine-Tax, would consent to improve its efficacy and eventually extend its application field without the necessity of using excipients. In fact, reviewing the literature, several papers disclose the use of excipients as a strategy to increase Tax bioavailability [ 56 , 57 , 58 , 59 , 60 ].…”
Section: Resultsmentioning
confidence: 99%
“…It is obtained from crustacea shells, insect cuticles, and cell walls of some fungi and is straight-chain amino polysaccharide (poly- 1,4-D-glucosamine) with many features which are favorable for its use in drug delivery 9. It is being highly explored for its application in oral delivery 10. Not only chitosan, but its derivatives like glycol chitosan, thiolated chitosan, arginine-chitosan, carboxymethyl chitosan, aminated chitosan are also being explored for the drug delivery application 11,12.…”
Section: Introductionmentioning
confidence: 99%
“…Inclusion complexes of the phenolic extracts (i.e., M2, M5, and E) and Syloid ® AL-1 (30:70, w : w ) were prepared using the solvent evaporation method [ 17 , 18 ]. In particular, the phenolic extract was solubilized in 10 mL ethanol, and Syloid ® AL-1 was then added to the solution that was left under magnetic stirring for 2 h. Ethanol was successively evaporated under vacuum, and the powder obtained was recovered and stored in a desiccator until further use.…”
Section: Methodsmentioning
confidence: 99%
“…An amount of inclusion complex was further processed to coat it with a lipid mixture (lauric acid:stearic acid, 77:33, w:w) characterized by a melting temperature of 37 °C. Briefly, the lipid mixture was melted at 40 °C, and the inclusion complex was added and stirred for 10 min [ 18 , 19 ]. The lipid:inclusion complex weight ratio was 1.1:1.…”
Section: Methodsmentioning
confidence: 99%